Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gejyo

Showing results (11-20 of 243) with videos related to

Pageof 25
Sort By:
Kidney International. Supplement|March 1, 1988
Beta 2-microglobulin: evidence for a new form of hemodialysis-associated amyloid proteinF Gejyo, M Arakawa
Journal of Internal Medicine|December 1, 1992
Beta 2-microglobulin-associated amyloidosesF Gejyo, M Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 30, 1999
[Apo-E phenotype]M Sakatsume, F Gejyo
Internal Medicine (Tokyo, Japan)|December 1, 1993
New type of amyloidosis. a). beta 2-Microglobulin and hemodialysisF Gejyo, M Arakawa
The International Journal of Artificial Organs|January 1, 1988
Beta-2-microglobulin: a possible new uremic toxin?F Gejyo, D Brancaccio
Biochimica Et Biophysica Acta|November 30, 1981
Purification and characterization of the two forms of human plasma alpha 2HS-glycoproteinF Gejyo, K Schmid
Contributions to Nephrology|January 1, 1990
Dialysis amyloidosis: current disease concepts and new perspectives for its treatmentF Gejyo, M Arakawa
Arerugi = [Allergy]|June 12, 2001
[Effect of Bakumondo-to on increased sensitivity of the cough reflex in a Sjögren syndrome patient with interstitial lung disease]K Fujimori, E Suzuki, F Gejyo
Kidney International. Supplement|June 1, 1993
Long-term complications of dialysis: pathogenic factors with special reference to amyloidosisF Gejyo, N Homma, M Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1992
[Prevention and therapy of dialysis amyloidosis]N Homma, F Gejyo, M Arakawa
Pageof 25

Showing results (11-20 of 243) with videos related to

Sort By:
Pageof 25
Kidney International. Supplement|March 1, 1988
Beta 2-microglobulin: evidence for a new form of hemodialysis-associated amyloid proteinF Gejyo, M Arakawa
Journal of Internal Medicine|December 1, 1992
Beta 2-microglobulin-associated amyloidosesF Gejyo, M Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 30, 1999
[Apo-E phenotype]M Sakatsume, F Gejyo
Internal Medicine (Tokyo, Japan)|December 1, 1993
New type of amyloidosis. a). beta 2-Microglobulin and hemodialysisF Gejyo, M Arakawa
The International Journal of Artificial Organs|January 1, 1988
Beta-2-microglobulin: a possible new uremic toxin?F Gejyo, D Brancaccio
Biochimica Et Biophysica Acta|November 30, 1981
Purification and characterization of the two forms of human plasma alpha 2HS-glycoproteinF Gejyo, K Schmid
Contributions to Nephrology|January 1, 1990
Dialysis amyloidosis: current disease concepts and new perspectives for its treatmentF Gejyo, M Arakawa
Arerugi = [Allergy]|June 12, 2001
[Effect of Bakumondo-to on increased sensitivity of the cough reflex in a Sjögren syndrome patient with interstitial lung disease]K Fujimori, E Suzuki, F Gejyo
Kidney International. Supplement|June 1, 1993
Long-term complications of dialysis: pathogenic factors with special reference to amyloidosisF Gejyo, N Homma, M Arakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1992
[Prevention and therapy of dialysis amyloidosis]N Homma, F Gejyo, M Arakawa
Pageof 25